At the 2016 Medical Innovation Summit, our committee of Cleveland Clinic caregivers ranked Cellular Immunotherapy to Treat Leukemia & Lymphomas as the #3 medical innovation predicted to make waves in 2017. Good news appeared recently in New Scientist that backs up the hype of CAR-T cells. Two young leukemia patients are currently showing no signs of cancer, thanks to this new gene-editing technique. This type of groundbreaking innovation will be discussed at the 2017 Medical Innovation Summit in a panel titled, CRISPR’s Business Quandary: Making Sense of the Gene Editing Market. Panelists will give audiences a glimpse at the companies that are trying to leverage dramatic research breakthrough known as CRISPR into patient-benefiting commercial products. Stay tuned for more information.